Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why ...

Hepatitis B virus-induced hepatocellular carcinoma (HCC) remains a major global health burden, and new therapeutic and ...

Hepatitis B virus-induced hepatocellular carcinoma (HCC) remains a major global health burden, and new therapeutic and ...

Asian Americans are disproportionately affected by hepatitis B, especially by chronic infections. Years of community work ...

Considering the general decline in funding for research and development, Africa CDC, in collaboration with the World Hepatitis Alliance (WHA) and the African Viral Hepatitis Action Group (AVHAG), has ...

In this Review, we summarise outputs from a multidisciplinary consultation convened by WHO between July 11 and 13, 2023, to discuss hepatitis B virus (HBV) drug resistance (HBVDR). Treatment of ...

Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV). While most people exposed to hepatitis B will spontaneously clear the virus ... What differentiates hepatitis B from ...

Through its precision cutting, compact design, and simple structure, PBGENE-HBV is engineered to target the HBV viral genome and drive functional cures for patients with chronic hepatitis B ...

The hepatitis B market size reached a value of USD 3.3 Billion in 2023. Looking forward, the market is expected to reach USD 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.83% during ...

Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP. Nature Communications , 2024; 15 (1) DOI: 10.1038/s41467-024-46706-w Cite This Page : ...